相关实验视频
Updated: Jul 18, 2025
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
656
使用深度学习建模小岛增强剂,在与T2D和血糖特征相关的位置确定候选因果变异
Sanjarbek Hudaiberdiev1, D Leland Taylor2, Wei Song1
1Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20892.
概括
一个新的深度学习模型通过分析胰腺小岛中的增强剂活性来优先考虑与2型糖尿病 (T2D) 相关的遗传变异. 这种方法可以更有效地识别潜在的因果变异,用于未来的功能研究.
科学领域:
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
- 分子生物学分子生物学
背景情况:
- 遗传关联研究已经确定了许多2型糖尿病 (T2D) 风险位置.
- 在这些位点内确定特定的因果变异仍然是一个重大挑战.
- 了解胰腺小岛等相关组织的变异性功能至关重要.
研究的目的:
- 开发和验证一种深度学习 (DL) 方法,用于预测序列变异对增强器的功能影响.
- 优先考虑T2D和相关的血糖特征的候选因果变异,使用岛屿特定的监管模式.
- 为T2D遗传变异分析提供公开可用的资源.
主要方法:
- 开发了一个DL模型来分析对胰腺小岛增强剂的序列变异效应.
- 在岛屿特定的转录因子 (TF) 监管模式上训练模型.
- 应用该模型来优先考虑T2D相关信号的链接不平衡区域的变异.
- 在胰腺小岛β细胞系中进行了候选变异的生化验证.
主要成果:
- DL模型成功地学习了特定于小岛的TF监管模式.
- 对于101个T2D遗传信号,该模型提名了一个可能的因果变异.
- 生物化学测定证实了在一种情况下对模型优先变异的TF结合的等位基效应.
- 该模型和相关得分发布了6700万个遗传变异.
结论:
- 深度学习模型可以通过预测增强器活动,有效地优先考虑T2D的候选因果变异.
- 这种方法提高了基因关联信号的功能研究的效率.
- 开发的资源将有助于研究人员剖析T2D的遗传结构.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:24Glucagon-like Receptor Agonists
358
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
358
01:20Pathophysiology of Diabetes
989
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989